24th August 2009, Lysaker, Norway - GreenPower and NattoPharma have entered into a license agreement giving GreenPower access to utilize the MenaQ7 brand and NattoPharma patents in their sales and marketing of vitamin K2.

NattoPharma's VP of Sales & Marketing, Siri Stabel Olsen says: "We are very pleased that GreenPower, a major direct mail company located in the Netherlands, see the higher benefit of vitamin K2 for the consumers. GreenPower is a very successful company developing, manufacturing and selling high-quality health-products. MenaQ7 will have a high priority in marketing and sales the coming years. "

 

 

###

 

 

MenaQ7, the Natural Vitamin K2 is extracted from fermented soybeans with guaranteed actives and stability, clinical substantiation and patents granted and pending. MenaQ7 provides the Natural K2 Vitamin in a form of menaquinone-7, the long chained molecule offering superior bioavailability and health effects in low doses, which has been tied to both bone and cardiovascular health.

For more information on the health benefits of MenaQ7, please visit www.menaq7.com.

 

NattoPharma, Norway, is the exclusive international supplier and brand-owner of MenaQ7, the most effective natural form of vitamin K2. Vitamin K2 (MK-7) was recently amended by the EU commission to the list of legally added vitamins for fortified food and food supplements. NattoPharma ASA is listed on the Oslo Axess list at the Oslo Stock Exchange. The company has established an extensive research and development program aimed at documenting the benefits of vitamin K2. Please see further information on  www.nattopharma.com

 

 

For more information, please contact

Morten Sundstø

CEO

Tel. +47 950 61 860

or

Siri Stabel Olsen

VP of Sales & Marketing

Tel. +47 992 52 274